These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31033145)

  • 21. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems.
    Lee SF; Zhu XM; Wang YX; Xuan SH; You Q; Chan WH; Wong CH; Wang F; Yu JC; Cheng CH; Leung KC
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1566-74. PubMed ID: 23402574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin.
    Rui M; Xin Y; Li R; Ge Y; Feng C; Xu X
    Mol Pharm; 2017 Jan; 14(1):107-123. PubMed ID: 27982602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy.
    Li T; Shen X; Geng Y; Chen Z; Li L; Li S; Yang H; Wu C; Zeng H; Liu Y
    ACS Appl Mater Interfaces; 2016 Jun; 8(22):13748-58. PubMed ID: 27191965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
    Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
    Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy.
    Yuan Y; Zhang Q; Yan Y; Gong M; Zhao Q; Bao Z; Liu K; Wang S
    Drug Deliv; 2018 Nov; 25(1):623-631. PubMed ID: 29463124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Loaded Nanoparticles of Metal-Organic Frameworks with High Colloidal Stability for Anticancer Application.
    Lai X; Liu H; Zheng Y; Wang Z; Chen Y
    J Biomed Nanotechnol; 2019 Aug; 15(8):1754-1763. PubMed ID: 31219022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
    Xu W; Lou Y; Chen W; Kang Y
    Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy.
    Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D
    Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
    Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
    Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 36. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
    Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomimetically grown apatite spheres from aggregated bioglass nanoparticles with ultrahigh porosity and surface area imply potential drug delivery and cell engineering applications.
    El-Fiqi A; Buitrago JO; Yang SH; Kim HW
    Acta Biomater; 2017 Sep; 60():38-49. PubMed ID: 28754647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy.
    Zhu Q; Jia L; Gao Z; Wang C; Jiang H; Zhang J; Dong L
    Mol Pharm; 2014 Oct; 11(10):3269-78. PubMed ID: 24735448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation.
    Xu Q; Wan J; Bie N; Song X; Yang X; Yong T; Zhao Y; Yang X; Gan L
    Theranostics; 2018; 8(19):5362-5378. PubMed ID: 30555552
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Li C; Yang XQ; Zhang MZ; Song YY; Cheng K; An J; Zhang XS; Xuan Y; Liu B; Zhao YD
    Theranostics; 2018; 8(20):5662-5675. PubMed ID: 30555572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.